Lassa antiviral LHF-535 protects guinea pigs from lethal challenge
Authors:
Open Access
- 19 November 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-7
Abstract
LHF-535 is a small molecule antiviral currently in development for the treatment of Lassa fever, a zoonotic disease endemic in West Africa that generates significant morbidity and mortality. Current treatment options are inadequate, and there are no approved therapeutics or vaccines for Lassa fever. LHF-535 was evaluated in a lethal guinea pig model of Lassa pathogenesis, using once-daily administration of a fixed dose (50 mg/kg/day) initiating either 1 or 3 days after inoculation with a lethal dose of Lassa virus. LHF-535 reduced viremia and clinical signs and protected all animals from lethality. A subset of surviving animals was rechallenged four months later with a second lethal challenge of Lassa virus and were found to be protected from disease. LHF-535 pharmacokinetics at the protective dose in guinea pigs showed plasma concentrations well within the range observed in clinical trials in healthy volunteers, supporting the continued development of LHF-535 as a Lassa therapeutic.Keywords
Funding Information
- Wellcome Trust (WT-200439/Z/16/Z, WT-200439/Z/16/Z, WT-200439/Z/16/Z, WT-200439/Z/16/Z, WT-200439/Z/16/Z, WT-200439/Z/16/Z, WT-200439/Z/16/Z, WT-200439/Z/16/Z, WT-200439/Z/16/Z)
This publication has 29 references indexed in Scilit:
- Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal ElectroporationVaccines, 2013
- Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory OperationPLOS Neglected Tropical Diseases, 2012
- The Curious Case of Arenavirus Entry, and Its InhibitionViruses, 2012
- Evaluation of Lassa antiviral compound ST-193 in a guinea pig modelAntiviral Research, 2011
- A Specific Interaction of Small Molecule Entry Inhibitors with the Envelope Glycoprotein Complex of the Junín Hemorrhagic Fever ArenavirusJournal of Biological Chemistry, 2011
- Identification of a Broad-Spectrum Arenavirus Entry InhibitorJournal of Virology, 2008
- pH-Induced Activation of Arenavirus Membrane Fusion Is Antagonized by Small-Molecule InhibitorsJournal of Virology, 2008
- Clinical Virology of Lassa Fever in Hospitalized PatientsThe Journal of Infectious Diseases, 1987
- A Prospective Study of the Epidemiology and Ecology of Lassa FeverThe Journal of Infectious Diseases, 1987
- Lassa FeverNew England Journal of Medicine, 1986